SCHEMBL24088136

SCHEMBL24088136

N#Cc1c(C(F)(F)F)cc(=O)[nH]c1SCC(=O)NO

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.76
▸ ALDH1A1 P00352 6/20 0.61
▸ MAPT P10636 4/20 0.61
▸ KMT2A Q03164 8/20 0.50
▸ MEN1 O00255 6/20 0.50
▸ HTT P42858 5/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ GAA P10253 1/20 0.50
▸ CRHBP P24387 1/20 0.50
▸ CRHR2 Q13324 1/20 0.50
▸ TSHR P16473 2/20 0.49
▸ LMNA P02545 4/20 0.48
▸ HSD17B10 Q99714 2/20 0.48
▸ ALOX15 P16050 1/20 0.48
▸ HPGD P15428 3/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ PKM P14618 1/20 0.44
▸ TP53 P04637 2/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26847329 0.89 KDM4E (0.74) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL20339508 0.86 KDM4E (1.00) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL24087959 0.85 KDM4E (0.68) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL20339938 0.84 KDM4E (0.74) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL24087954 0.83 KDM4E (0.65) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL20350983 0.81 KDM4E (0.69) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL20350841 0.80 KDM4E (0.70) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL20339496 0.79 KDM4E (0.70) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL20350847 0.79 KDM4E (0.66) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL20340095 0.79 KDM4E (0.77) KDM4EALDH1A1MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed
US-20210379069-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S R L (IT) 2021-12-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 KDM4E 1110/4885ALDH1A1 171/4885MAPT 1263/4885
US-20210379069-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 KDM4E 1110/4885ALDH1A1 171/4885MAPT 1263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback